Cost-effectiveness of upstream versus selective glycoprotein IIb/IIIa inhibitors for acute coronary syndromes.

Source:http://linkedlifedata.com/resource/pubmed/id/17222743

J. Am. Coll. Cardiol. 2007 Jan 16 49 2 276; author reply 277

Download in:

View as

Triples

General Info

PMID
17222743